John S. Montalbano - 01 Mar 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney in fact
Issuer symbol
ABCL
Transactions as of
01 Mar 2022
Net transactions value
+$181,000
Form type
4
Filing time
03 Mar 2022, 11:06:01 UTC
Previous filing
10 Dec 2021
Next filing
04 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $181,000 +20,000 +77% $9.05 46,000 01 Mar 2022 Direct
holding ABCL Common Shares 5,000 01 Mar 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.